Method of applying a buttress to a surgical stapler end effector

US12349899B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12349899-B2
Application numberUS-202217950226-A
CountryUS
Kind codeB2
Filing dateSep 22, 2022
Priority dateAug 24, 2015
Publication dateJul 8, 2025
Grant dateJul 8, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A buttress is applied to an end effector of a surgical stapler. The buttress is loaded on a platform of a buttress applier cartridge. The end effector is closed upon the platform. An adhesive layer of the buttress secures the buttress to the end effector. The buttress is thus adhered to the end effector when the end effector is opened. The end effector is then actuated on tissue of a patient, thereby stapling the buttress to the tissue.

First claim

Opening claim text (preview).

We claim: 1. A buttress assembly configured for use with an end effector of a surgical stapler, comprising: (a) a buttress body; and (b) an adhesive layer disposed over the buttress body, wherein the adhesive layer includes a pressure sensitive adhesive having an embedded medicant, wherein the adhesive layer is configured to releasably adhere to one of an anvil or a stapling assembly of the end effector in response to closure of the end effector on the buttress assembly, wherein the buttress body is configured to contact tissue clamped by the end effector during closure thereof, wherein the buttress body is further configured to be pierced and captured by staples ejected from the stapling assembly into the clamped tissue and thereby reinforce the engagement between the ejected staples with the clamped tissue, wherein the embedded medicant is configured to affect a physiological response in the clamped tissue. 2. The buttress assembly of claim 1 , wherein the adhesive layer is configured to release the embedded medicant to the tissue. 3. The buttress assembly of claim 2 , wherein the adhesive layer is configured to release the embedded medicant to the tissue substantially immediately in response to the buttress body being pierced and captured by the staples ejected from the stapling assembly into the clamped tissue. 4. The buttress assembly of claim 1 , wherein the embedded medicant includes a hemostatic agent. 5. The buttress assembly of claim 1 , wherein the embedded medicant includes an adhesion prevention agent. 6. The buttress assembly of claim 1 , wherein the embedded medicant includes a healing cascade impacting agent. 7. The buttress assembly of claim 1 , wherein the embedded medicant includes an antimicrobial agent. 8. The buttress assembly of claim 1 , wherein the pressure sensitive adhesive is absorbable. 9. The buttress assembly of claim 1 , wherein the pressure sensitive adhesive includes a polymer. 10. The buttress assembly of claim 1 , wherein the pressure sensitive adhesive includes an organic adhesive blend. 11. The buttress assembly of claim 10 , wherein the organic adhesive blend includes one or more plastic fats. 12. The buttress assembly of claim 10 , wherein the organic adhesive blend includes one or more sorbents. 13. The buttress assembly of claim 1 , wherein at least the buttress body of the buttress assembly is configured to separate from the one of the anvil or the stapling assembly in response to opening of the end effector after the staples have been ejected into the clamped tissue. 14. A buttress applier cartridge configured for use with an end effector of a surgical stapler, comprising: (a) a platform; (b) the buttress assembly of claim 1 disposed on the platform; and (c) a retainer configured to releasably retain the buttress assembly on the platform. 15. An assembly, comprising: (a) an end effector, comprising: (i) an anvil, and (ii) a stapling assembly; and (b) the buttress assembly of claim 1 , wherein the adhesive layer of the buttress assembly is releasably adhered to one of the anvil or the stapling assembly of the end effector. 16. The buttress assembly of claim 1 , wherein the pressure sensitive adhesive is flowable. 17. The buttress assembly of claim 1 , wherein the adhesive layer covers an upper surface of the buttress body. 18. The buttress assembly of claim 1 , wherein the adhesive layer is exposed. 19. A buttress assembly configured for use with an end effector of a surgical stapler, comprising: (a) a buttress body; and (b) an adhesive layer disposed over the buttress body, wherein the adhesive layer includes a pressure sensitive adhesive having an embedded medicant, wherein the adhesive layer is configured to releasably adhere to one of an anvil or a stapling assembly of the end effector in response to closure of the end effector on the buttress assembly, wherein the buttress body is configured to contact tissue clamped by the end effector during closure thereof, wherein the buttress body is further configured to be pierced and captured by staples ejected from the stapling assembly into the clamped tissue and thereby reinforce the engagement between the ejected staples with the clamped tissue, wherein the embedded medicant is configured to affect a physiological response in the clamped tissue, wherein the embedded medicant includes both a hemostatic agent and an adhesion prevention agent. 20. A buttress assembly configured for use with an end effector of a surgical stapler, comprising: (a) a buttress body; and (b) an adhesive layer disposed over the buttress body, wherein the adhesive layer includes a pressure sensitive adhesive having an embedded medicant, wherein the adhesive layer is configured to releasably adhere to one of an anvil or a stapling assembly of the end effector in response to closure of the end effector on the buttress assembly, wherein the buttress body is configured to contact tissue clamped by the end effector during closure thereof, wherein the buttress body is further configured to be pierced and captured by staples ejected from the stapling assembly into the clamped tissue and thereby reinforce the engagement between the ejected staples with the clamped tissue, wherein the embedded medicant is configured to affect a physiological response in the clamped tissue, wherein the pressure sensitive adhesive is both flowable and absorbable.

Assignees

Inventors

Classifications

  • Surgical gloves; Finger-stalls specially adapted for surgery; Devices for handling or treatment thereof · CPC title

  • Flexible bags or pouches · CPC title

  • Carrying cases or bags, e.g. doctors' bags · CPC title

  • Peelable cover · CPC title

  • parallel to the lid plane · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12349899B2 cover?
A buttress is applied to an end effector of a surgical stapler. The buttress is loaded on a platform of a buttress applier cartridge. The end effector is closed upon the platform. An adhesive layer of the buttress secures the buttress to the end effector. The buttress is thus adhered to the end effector when the end effector is opened. The end effector is then actuated on tissue of a patient, t…
Who is the assignee on this patent?
Cilag Gmbh Int
What technology area does this patent fall under?
Primary CPC classification A61B17/07207. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).